A recent study has revealed that the endocannabinoid system may provide a novel treatment for alcoholism. Researchers have found that cannabinoid receptor 2 (CB2) is able to modulate the reward pathway for alcohol consumption. Specifically, when CB2 is antagonized.
CANNABINOID RECEPTOR 2 IS NOVEL TARGET FOR TREATMENT OF ALCOHOLISM
